Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

[video]3 Biggest Biotech Crashes in April
Motley Fool
Thursday, May 2, 2013 - 10:36am
tags:
Dyax, Rigel Pharmaceuticals, Sarepta, AstraZeneca
Impax Laboratories Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Thursday, May 2, 2013 - 10:34am
tags:
Impax Laboratories, earnings
Big Pharma's Kickback Conundrum
Motley Fool
Thursday, May 2, 2013 - 10:33am
tags:
Pfizer, kickbacks, GSK, Novartis
Sanofi 1Q net drops 45 percent as generic competition slashes sales of Plavix, other drugs
Yahoo/AP
Thursday, May 2, 2013 - 10:31am
tags:
Sanofi, earnings
Genmab Rises After FDA Grants Breakthrough Status to Cancer Drug
Bloomberg
Thursday, May 2, 2013 - 10:31am
tags:
Genmab, FDA, JNJ, daratumumab, Multiple Myeloma
Shire cuts sales forecast as some drugs miss Q1 targets
Reuters
Thursday, May 2, 2013 - 10:29am
tags:
earnings, Shire
Regeneron Pharmaceuticals Earnings Preview: Can This Streak Continue?
Wall St. Cheat Sheet
Thursday, May 2, 2013 - 10:29am
tags:
earnings, Regeneron
Gilead combo hepatitis C pill shown effective in small trial
Reuters
Thursday, May 2, 2013 - 10:28am
tags:
hepatitis C, Gilead, ledipasvir, sofosbuvir
Gilead Sciences Earnings Preview: Get Ahead of the Analysts
Wall St. Cheat Sheet
Thursday, May 2, 2013 - 10:27am
tags:
earnings, Gilead
Allergan shares fall on delay of eye drug study
Yahoo/AP
Wednesday, May 1, 2013 - 4:05pm
tags:
Allergan, Eylea, Regeneron
Weak Quarter At Auxilium Overshadows Execution On Long-Term Strategy
Seeking Alpha
Wednesday, May 1, 2013 - 4:03pm
tags:
Auxilium, earnings
Allergan Evaluates Bids for its Lap-Band Weight Loss Product
Bloomberg
Wednesday, May 1, 2013 - 11:38am
tags:
Allergan, Lap-Band, M&A
Merck spotlights new deals, R&D review as demands to rebuild pipeline grow
Fierce Biotech
Wednesday, May 1, 2013 - 11:06am
tags:
Merck, R&D
Regeneron execs score $140M payday as Eylea mints money
Fierce Pharma
Wednesday, May 1, 2013 - 11:05am
tags:
Regeneron, Eylea, executive pay
With A New Institutional Investor On Board, Northwest Biotherapeutics Breaks The Curse
Seeking Alpha
Wednesday, May 1, 2013 - 11:03am
tags:
Northwest Biotherapeutics
Exact Sciences Earnings: Here’s Why Investors are Not Happy Now
Wall St. Cheat Sheet
Wednesday, May 1, 2013 - 11:03am
tags:
EXACT Sciences, earnings
ViroPharma Earnings: Here’s Why the Stock is Down Now
Wall St. Cheat Sheet
Wednesday, May 1, 2013 - 11:02am
tags:
earnings, ViroPharma
OXiGENE's Oncology Drugs Have Run Their Course
Seeking Alpha
Wednesday, May 1, 2013 - 11:01am
tags:
Oxigene, oncology
Vivus And Anti-Obesity Sector Benefit From New Insurance Deal
Seeking Alpha
Wednesday, May 1, 2013 - 9:54am
tags:
Vivus, obesity, Orexigen, Arena Pharmaceuticals, Qsymia, Medco
FDA rejects Titan drug for opioid dependence
Reuters
Wednesday, May 1, 2013 - 9:49am
tags:
FDA, Titan Pharmaceuticals, opioid addiction, Probuphine

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.